WHWK 8-K: SEC filing

Whitehawk Therapeutics

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-452704

WHWK filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Whitehawk Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantWhitehawk Therapeutics, Inc.

Chief financial officerScott Giacobello

✦ Ask GOAX AI about this filing — what it means for WHWK, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for WHWK?

Click here

Frequently asked questions

What did WHWK file with the SEC on Nov 9, 2026?

WHWK filed a 8-K (SEC filing). Whitehawk Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other WHWK SEC filings

Get alerts when WHWK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

WHWK overview WHWK analysis WHWK news Latest SEC filings